Merit Medical Systems, Inc. (MMSI) - Cumulative Company Assets

Public company logo of Merit Medical Systems, Inc. (MMSI)

The primary driver for Merit Medical Systems (MMSI) is the automation of disposable catheter production for global distribution. The company's current asset level clearly demonstrates this growth, while the 2725.84 metric confirms the current level of resources. Stability is maintained by outsourcing logistics and sterilization to external partners. Additional potential lies in expansion through the acquisition of niche developers to strengthen the distribution network.

Merit Medical Systems, Inc. (MMSI) Company Total Assets: for the period 07/04/2022 - 10/27/2026

Comprehensive metric breakdowns and analytics for Merit Medical Systems Inc (MMSI)

- price and consensus price forecast:
Market Chart merit.com|MMSI - Price Target Chart
- market capitalization data:
Market Valuation Merit Medical Systems|MMSI - Enterprise Value
- book capitalization data:
Net Asset Value per Share Merit Medical|MMSI - Book Capitalization|Capitalization to Book Value Ratio merit.com|MMSI - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Coefficient Merit Medical Systems|MMSI - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Merit Medical Corp|MMSI - Company Aggregate Debts|Debts to Book Capitalization Merit Medical Systems
Fundamental valuation:merit.com, MMSI
Manufactured product of Merit Medical Systems

Scaling the production of eco-friendly medical instruments at Merit Medical Systems (MMSI) requires significant capital expenditures to optimize sterilization and reduce waste. By analyzing the total asset forecast calculated reverse-engineered through ROA, the investor assesses the total value of resources and liabilities, separating organic base growth from the risks of excessive borrowing to confirm the fundamental stability of the business.

Main competitors

ISRG (intuitive.com) - Company Total Asset Base|Aggregate Company Assets DHR|Cumulative Company Assets BD|STERIS Corporation - Company Total Assets|Company Assets West Pharma Corp (WST)|BAX - Company Total Assets|Total Business Assets masimo.com MASI|Company Total Assets STVN (Stevanato Group)|TFX - Company Total Asset Base|NVST (Envista Holdings Corp) - Company Total Assets|ICU Medical Inc. (ICUI) - Cumulative Company Assets|XRAY (DENTSPLY SIRONA Inc.) - Company Total Assets|Company Total Assets LMAT|Aggregate Company Assets AtriCure (ATRC)|Aggregate Company Assets STAAR Surgical Co. STAA|Cumulative Company Assets niagenbioscience.com|Aggregate Asset Value ZimVie Corp ZIMV|Company Total Assets ANGO (AngioDynamics, Inc.)|CERS: Company Total Asset Base|Aggregate Company Assets Teknova|MGRM (Monogram Technologies Inc.) - Total Business Assets|STSS: Aggregate Company Assets|Company Total Asset Base InfuSystem Inc (INFU)|Cumulative Company Assets Utah Medical Products|Aggregate Business Assets KRMD (korumedical.com)|Aggregate Company Assets Nyxoah|MBOT - Aggregate Asset Value|Pro-Dex Corp - Cumulative Company Assets|ZTEK: Company Total Assets|ELUT (Elutia Inc.) - Aggregate Company Assets|milestonescientific.com (MLSS) - Cumulative Company Assets|Company Total Assets NXGL (NEXGEL)|Company Assets RVP|Aggregate Company Assets Harvard Bioscience HBIO|Total Business Assets Femasys Corporation FEMY|Cumulative Company Assets Meihua Medical Technologies Co., Ltd. (MHUA)|Predictive Oncology Inc - Aggregate Business Assets|Aggregate Company Assets CJMB (Callan JMB Corp)|ATRI: Company Total Asset Base|NURO (NeuroMetrix Corp) - Aggregate Company Assets